Ameriprise
PIIIW icon

Ameriprise’s P3 Health Partners Inc Warrant PIIIW Stock Holding History

Ameriprise’s Portfolio PIIIW Stock Details PIIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-494,549
Closed -$519K – 4004
2021
Q4 		$519K Buy
+494,549
New +$599K ﹤0.01% 3513

Other funds holding PIIIW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
SAMU
SONA Asset Management (US) New York $4.74B AUM 11.18% 1-Year Est. Return

Ameriprise's PIIIW Position: Q1 2022 in Review

Ameriprise sold out of P3 Health Partners Inc Warrant (PIIIW) in Q1 2022, closing a stake of 494,549 shares — an estimated $519K sold.

Ameriprise first reported a position in PIIIW in Q4 2021 and held it in 1 quarter. The position peaked at $519K in Q4 2021. 29 funds tracked by Wall St. Rank hold PIIIW as of Q1 2022.

  • Ameriprise reported no remaining P3 Health Partners Inc Warrant position as of Q1 2022 after selling out during the quarter.
  • Ameriprise sold 494,549 P3 Health Partners Inc Warrant shares in Q1 2022, an estimated $519K.
  • Ameriprise first reported a position in P3 Health Partners Inc Warrant in Q4 2021 and held it in 1 quarter.
  • Ameriprise's P3 Health Partners Inc Warrant position peaked at $519K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held P3 Health Partners Inc Warrant as of Q1 2022.

Based on Ameriprise's 13F filing for Q1 2022, filed 16 May 2022.